Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

StimAire implants UAVC funding

UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.


Nov 19, 2019

Initial Recommendations for Improving DEI within CVC Deal Flow Pipelines and Portfolios

Diversity, Equity and Inclusion (DEI) report October 2019

Nov 19, 2019

CL Educate clears university startup funding

The education services provider is set to invest $4.2m in university-based startups in support of open innovation platform Wain Connect.

Nov 19, 2019

Siren attracts $10m for series A round

Atlantic Bridge led a round for NUI Galway-founded organisational data investigation spinout Siren, having backed the company's seed round through its University Bridge Fund.

Nov 18, 2019

Oil and gas drills into non-core

A focus shift has been taking place among oil and gas corporate venturers, which is borne out in our most recent research.

Nov 17, 2019

Daily deal net: November 15, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 15, 2019

AMP amplifies $16m

UC-backed Congruent Ventures has returned to take part in a series A round for waste recycling robot company AMP Robotics.

Nov 15, 2019

Daily deal net: November 14, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 14, 2019

Sera Prognostics diagnoses $36m series D

Based on research from Brigham Young University and University of Utah, Sera has added $36m to its funding vault to drive commercialisation of its blood testing system PreTRM.

Nov 14, 2019

PMV pinpoints $62m investment

OUP returned for PMV's series C round which the company will use to cement its portfolio of small molecule treatments targeting cancerous p53 mutations.

Nov 14, 2019

EpicentRx rustles up $35m

Building on UCSD intellectual property, EpicentRx is working on immunotherapy drugs intended to target the body's non-specific and adaptive specific immune function synchronously.

Nov 14, 2019

Frontier IP fields $3.1m profit

Frontier IP booked increases for 2018-19 across the board in terms of cash holdings, portfolio value and pre-tax profit.

Nov 14, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here